hesperidin has been researched along with Fatty Liver, Nonalcoholic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 9 (90.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Lei, M; Li, Z; Xie, Q | 1 |
| Chen, H; Ma, J; Nie, T; Shan, A; Zhang, P | 1 |
| Chen, F; Deng, ZY; Hua, L; Li, X; Luo, T; Wang, Y; Wu, M; Yao, Y | 1 |
| Chen, J; Ge, A; Ge, J; Wang, S; Xu, H; Yang, K; Yuan, X; Zeng, L; Zhang, T | 1 |
| Feng, S; Han, H; Shi, M; Tang, J; Wang, L; Zhang, T | 1 |
| Alavian, SM; Cheraghpour, M; Eini-Zinab, H; Hedayati, M; Hekmatdoost, A; Yari, Z | 1 |
| Bai, YF; Fan, XY; Lou, LJ; Sheng, H; Wang, SW; Weng, YY; Zhang, F | 1 |
| Li, J; Liu, P; Sun, W; Wang, T; Wang, X; Yang, F; Zheng, W | 1 |
| Chatuphonprasert, W; Jarukamjorn, K; Sukkasem, N | 1 |
| Alavian, SM; Cheraghpour, M; Hedayati, M; Hekmatdoost, A; Imani, H; Karimi-Shahrbabak, E; Ommi, S; Yari, Z | 1 |
1 review(s) available for hesperidin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Topics: Alanine Transaminase; Anthocyanins; Aspartate Aminotransferases; Catechin; Cholesterol, HDL; Cholesterol, LDL; Curcumin; Dietary Supplements; Genistein; Hesperidin; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Plant Extracts; Polyphenols; Resveratrol; Silymarin; Triglycerides | 2022 |
2 trial(s) available for hesperidin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial.
Topics: Dietary Supplements; Flax; Hesperidin; Humans; Insulin Resistance; Liver; Non-alcoholic Fatty Liver Disease | 2021 |
Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Topics: Alanine Transaminase; Alkaline Phosphatase; Double-Blind Method; Female; Hesperidin; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2019 |
7 other study(ies) available for hesperidin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.
Topics: Animals; Biomarkers; Diet, High-Fat; Endoplasmic Reticulum Stress; Endoribonucleases; Hesperidin; Inflammation; Interleukin-6; Liver; Non-alcoholic Fatty Liver Disease; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2022 |
Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Enzyme Activation; Hep G2 Cells; Hesperidin; Humans; Lipid Metabolism; Lipids; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phosphorylation | 2022 |
Effect of Hesperidin Supplementation on Liver Metabolomics and Gut Microbiota in a High-Fat Diet-Induced NAFLD Mice Model.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Gastrointestinal Microbiome; Hesperidin; Lipid Metabolism; Liver; Male; Metabolomics; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2022 |
Study on the mechanism of Shuganzhi Tablet against nonalcoholic fatty liver disease and lipid regulation effects of its main substances in vitro.
Topics: Animals; Cholesterol; Diet, High-Fat; Emodin; Hesperidin; Lipid Metabolism; Lipids; Liver; Non-alcoholic Fatty Liver Disease; PPAR gamma; Rats; Resveratrol | 2023 |
Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hesperidin; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2020 |
Hesperetin ameliorates hepatic oxidative stress and inflammation
Topics: Animals; Antioxidant Response Elements; Diet, High-Fat; Hep G2 Cells; Hepatocytes; Hesperidin; Humans; Interleukin-6; Lipid Metabolism; Liver; Liver Cirrhosis; Male; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Transcription Factor RelA; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2021 |
Hesperidin, a novel candidate for the successful treatment of high fat diet plus ethanol-induced fatty liver disease in mice.
Topics: Animals; Diet, High-Fat; Ethanol; Female; Hesperidin; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease | 2021 |